Oberursel, Germany

Harry Abts

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Celonic Ag. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry Abts. Retrieved from https://idiyas.com/inventor/harry-abts

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Harry Abts

Introduction

Harry Abts is a notable inventor based in Oberursel, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. His work focuses on developing methods and materials that enhance the efficiency of producing high-yield cell lines.

Latest Patents

Harry Abts holds a patent for "Methods and materials for the reproducible generation of high producer cell lines for recombinant proteins." This invention is crucial in the production of recombinant gene products in eukaryotic cells. It encompasses specific vector systems, genetically engineered host cells, and methods of use, allowing for fast and reproducible generation of production cell lines suitable for large-scale production.

Career Highlights

Abts is associated with Celonic AG, a company that specializes in biopharmaceutical development and manufacturing. His role at Celonic AG has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in the biotechnology sector.

Collaborations

Harry Abts has collaborated with notable colleagues such as Andreas Herrmann and Benedikt Greulich. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in biotechnology.

Conclusion

Harry Abts is a prominent figure in the field of biotechnology, with a focus on improving the production of recombinant proteins. His patent and work at Celonic AG highlight his commitment to innovation and excellence in this vital area of research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…